$SNPS

Synopsys Prediction: Analysts See 25% Upside After Q3 Beat and Raised Guidance

Synopsys reported Q3 FY2026 revenue of $2.48B, up 42.4% YoY, and raised full-year guidance. Analysts at 24/7 Wall St. predict a 25% upside to $496.97, citing strong fundamentals and AI-driven growth. However, shares are down 15.45% YTD due to China-related challenges and high valuation.

Original reporting
Published Sep 12, 2026, 3:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 13, 2026, 4:50 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$SNPS
Bullish
high confidence
Mentioned
$SNPS
Relevance
8/10
AlphAI data visualization · based on kobaran.com
Decision brief

The 30-second read

$SNPSBullishMed
01

Why it matters

The earnings beat and guidance lift suggest a re‑rating opportunity, but execution risk from China restrictions and integration costs remain.

02

Market read

Strong earnings and guidance could narrow the gap between price and analyst targets, influencing AI‑related tech stocks.

03

What to watch

High restructuring and amortization charges may pressure GAAP earnings despite non‑cash nature.

Relevance 8/10Novelty 8/10Timing: post‑earnings release today

Background

Synopsys' Q3 results and guidance raise come amid AI‑driven demand and ongoing Ansys integration.

Company-level read

Ticker impact

$SNPSBullishHigh confidence
Context

Synopsys reported Q3 FY2026 revenue of $2.48B and raised full-year guidance to $9.715B revenue and $15.07 EPS.

Expected impact

Potential upside of 15‑25% if market digests the guidance lift.

Evidence & confidence

Guidance raise and strong revenue growth address prior price lag, aligning with analyst buy models.

Market effects

Highlights AI‑driven demand in EDA and simulation, supporting sector peers.

U.S. tech sector may see modest lift; China exposure remains a risk.

Reinforces broader AI‑related growth narrative across markets.

Counterpoint

China export controls could dampen near‑term demand, limiting upside.

Key entities

  • Synopsys

    EDA software provider reporting Q3 results.

  • Ansys

    Acquired firm whose integration drives future synergies.

Related articles

$AMZNMedAI 8/10

Amazon and Synopsys seal $1bn technology partnership

Amazon and Synopsys have signed a $1 billion deal to accelerate Amazon's custom silicon innovation and advance AI products and cloud infrastructure. The multi-year agreement builds on 15 years of collaboration, with Synopsys providing application-optimized silicon IP. Amazon's Peter DeSantis highlighted the impact of custom silicon on AWS, while Synopsys' Sassine Ghazi emphasized the partnership's role in shaping AI-native engineering.

$SNPSMed

Morgan Stanley Thinks Synopsys’ AI Story Isn’t Priced In

Morgan Stanley raised its price target for Synopsys to $574 from $500, forecasting fiscal 2027 EPS of $19.12. The firm believes Synopsys' AI story isn't fully priced in, but a re-rating depends on execution and proof of usage revenue growth. Investors will watch for metrics like customer retention and contracted backlog.

$SNPSMed

Morgan Stanley Raises Synopsys (SNPS) Price Target Amid AI Tailw

Morgan Stanley raised Synopsys' (SNPS) price target to $574 from $550, citing AI growth potential. SNPS shares dipped 0.8% premarket. GF Value™ estimates intrinsic value at $661.95, 32.8% above current price. SNPS has a GF Score™ of 93/100, reflecting strong growth and profitability. The stock's P/E ratio is 78.61x, below its 5-year median of 59.07x.